THE HYPOGLYCEMIC AND INSULINASE INHIBITORY ACTION OF L-TRYPTOPHAN1

I. Arthur Mirsky, Gladys Perisutti, D Diengott, Robert N. Jinks

Endocrinology · 1956 · 45 citations · 0 references

Concepts

Abstract

THE inactivation and degradation of insulin by the intact animal (1) and by homogenates and slices of liver (2, 3, 4) is dependent upon the activity of an enzyme system, insulinase, which is relatively specific in catalyzing the hydrolysis of insulin (5, 6). The action of insulinase can be competitively inhibited both in vitro (7) and in vivo (8) by a non-protein fraction of liver. This fraction, which appears to be a peptide, is referred to tentatively as “insulinase-inhibitor.” During the course of studies on the purification and identification of “insulinase-inhibitor,” it became pertinent to determine the effect of a variety of synthetic peptides on the destruction of insulin by liver homogenates. These studies led to the observation that carbobenzoxy-1-tryptophan is a potent competitive inhibitor of insulinase in vitro whereas other carbobenzoxyamino acids are ineffective.